FDA Warning Letter — Ultimart/BP

Case 510264 — FEI 3012815866

The FDA took a Warning Letter action against Ultimart/BP on Nov 10, 2016 (Berlin, WI). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Ultimart/BP
Date
Nov 10, 2016
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Berlin, WI (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.